102 related articles for article (PubMed ID: 8862173)
1. On the strategy of using nonviral carriers in cancer gene therapy.
Sochanik A; Szala S
Acta Biochim Pol; 1996; 43(2):293-300. PubMed ID: 8862173
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus vectors: use and optimisation in cancer gene therapy.
Blechacz B; Russell SJ
Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896
[TBL] [Abstract][Full Text] [Related]
3. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
4. Targeted gene-delivery strategies for angiostatic cancer treatment.
Brandwijk RJ; Griffioen AW; Thijssen VL
Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
[TBL] [Abstract][Full Text] [Related]
5. Viral and non-viral vectors for cancer gene therapy.
Cristiano RJ
Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
[TBL] [Abstract][Full Text] [Related]
6. New strategies for cancer gene therapy: progress and opportunities.
Cao S; Cripps A; Wei MQ
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):108-14. PubMed ID: 19671071
[TBL] [Abstract][Full Text] [Related]
7. Current status of polymeric gene delivery systems.
Park TG; Jeong JH; Kim SW
Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003
[TBL] [Abstract][Full Text] [Related]
8. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms.
Itaka K; Kataoka K
Eur J Pharm Biopharm; 2009 Mar; 71(3):475-83. PubMed ID: 18955136
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery for lung cancer using nonviral gene vectors.
Wang JT; Peng DY; Chen M; Ye JS
Pharmazie; 2007 Oct; 62(10):723-6. PubMed ID: 18236772
[TBL] [Abstract][Full Text] [Related]
10. Vector retargeting for cancer gene therapy.
Wei W; Xue JL; Tian L
Ai Zheng; 2009 Jan; 28(1):86-90. PubMed ID: 19448427
[TBL] [Abstract][Full Text] [Related]
11. Gelatin-based delivery systems for cancer gene therapy.
Nezhadi SH; Choong PF; Lotfipour F; Dass CR
J Drug Target; 2009 Dec; 17(10):731-8. PubMed ID: 19863194
[TBL] [Abstract][Full Text] [Related]
12. Targeting of therapeutics to the liver: liposomes and viral vectors.
Di Campli C; Wu J; Zern MA
Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421
[TBL] [Abstract][Full Text] [Related]
13. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
14. Designing nonviral vectors for efficient gene transfer and long-term gene expression.
Jackson DA; Juranek S; Lipps HJ
Mol Ther; 2006 Nov; 14(5):613-26. PubMed ID: 16784894
[TBL] [Abstract][Full Text] [Related]
15. Targeted polymers for gene delivery.
Hughes JA; Rao GA
Expert Opin Drug Deliv; 2005 Jan; 2(1):145-57. PubMed ID: 16296741
[TBL] [Abstract][Full Text] [Related]
16. Nonviral gene therapy approaches to hemophilia.
Gómez-Vargas A; Hortelano G
Semin Thromb Hemost; 2004 Apr; 30(2):197-204. PubMed ID: 15118931
[TBL] [Abstract][Full Text] [Related]
17. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets.
Burke B; Sumner S; Maitland N; Lewis CE
J Leukoc Biol; 2002 Sep; 72(3):417-28. PubMed ID: 12223508
[TBL] [Abstract][Full Text] [Related]
18. Strategies for cancer gene therapy.
Hughes RM
J Surg Oncol; 2004 Jan; 85(1):28-35. PubMed ID: 14696084
[TBL] [Abstract][Full Text] [Related]
19. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.
Khalil IA; Kogure K; Akita H; Harashima H
Pharmacol Rev; 2006 Mar; 58(1):32-45. PubMed ID: 16507881
[TBL] [Abstract][Full Text] [Related]
20. Folate-targeted non-viral DNA vectors for cancer gene therapy.
Ward CM
Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
